Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial.
JAMA Oncol
; 9(6): 779-789, 2023 06 01.
Article
in En
| MEDLINE
| ID: mdl-37022706
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Squamous Cell
/
Head and Neck Neoplasms
Type of study:
Clinical_trials
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
JAMA Oncol
Year:
2023
Document type:
Article
Affiliation country: